Data from EMC - Curated by EPG Health - Last updated 10 August 2016

Indication(s)

Vepesid is an anti-neoplastic drug for intravenous or oral use, which can be used alone or in combination with other oncolytic drugs.

Present data indicate that Vepesid is applicable in the therapy of: small cell lung cancer, resistant non-seminomatous testicular carcinoma.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Biosimilars in Oncology Knowledge Centre

Biosimilars in Oncology Knowledge Centre

What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Bristol-Myers Pharmaceuticals